Stand if You Can: A Standing Intervention in Long Term Care
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03796039 |
|
Recruitment Status :
Completed
First Posted : January 8, 2019
Results First Posted : July 6, 2021
Last Update Posted : July 13, 2021
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Frailty Sedentary Behavior Physical Disability | Behavioral: Standing | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 97 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | Long term care (LTC) facilities will be recruited, with half of the LTC facilities randomized as the intervention (n=2) and half as the control group (n=2). |
| Masking: | Single (Investigator) |
| Masking Description: | Investigator was masked at pre-testing. It was unknown which participants would be receiving the intervention. However, due to resources this was not repeated at post testing |
| Primary Purpose: | Supportive Care |
| Official Title: | Stand if You Can- A Randomized Control Trial |
| Actual Study Start Date : | April 1, 2019 |
| Actual Primary Completion Date : | January 23, 2020 |
| Actual Study Completion Date : | July 15, 2020 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Standing and Social Intervention
Participants be exposed to an additional 100 minutes of standing per week. Participants will do this by standing for 20 minutes Monday through Friday.
|
Behavioral: Standing
Standing for an additional 100 minutes per week; 20 minutes Monday-Friday |
|
No Intervention: Control Group
Control group will receive social visits, but no exposure to standing
|
- Changes in Walking Speed [ Time Frame: Pre and post intervention testing ]Measured by the 10m walking speed test
- Change in Balance [ Time Frame: Pre and post testing (following the 5 month intervention). Data was collected but investigators are still analyzing findings. ]Measured by a portable device (Wii Balance board), which has sensors that detects sway .
- Change in Leg Strength [ Time Frame: Pre-Post Testing (following the 5 month intervention) ]Using hand-held dynamometer to quantify leg strength through knee extension
- Change Lower Limb Power [ Time Frame: Pre-Post Testing (following the 5 month intervention) ]Using the 30second sit-stand test following senior fitness test protocol
- Change in Anxiety Symptoms [ Time Frame: Pre-Post Testing (following the 5 month intervention) ]The Geriatric Anxiety Inventory (Scale 0-20). A low score means a better outcome.
- Depression [ Time Frame: Pre-Post Testing (following the 5 month intervention) ]Geriatric Depression Scale Short Form (0-15 scale). Lower score is better outcome.
- Loneliness [ Time Frame: Pre-Post Testing (following the 5 month intervention) ]Loneliness was measured using the UCLA Loneliness Scale (20-80). A low score indicates a better outcome
- Fall Efficacy [ Time Frame: Pre-Post Testing (following the 5 month intervention) ]Falls Efficacy Scale-International Questionnaire (16-64 scale). Low score indicates a better score
- Rate of Falls [ Time Frame: The number of falls will be collected from three timeframes: 1. Between 6 months prior to and the start of program 2. the duration of the program (5 months) 3. From the end of the program to 6 months follow up. Data is still being analyzed at this time. ]Falls, injuries due to falls and hospitalization will be collected at 3 timepoints
- Metabolic Profile - Triglycerides [ Time Frame: Pre-Post Testing (before and following the 5 month intervention). ]Capillary blood analyzed with a cardiochek device. Blood collected via a finger prick and analyzed with a cardiochek device. Note that Total Cholesterol, HDL, Triglycerides, LDL and Glucose were all measured using the cardiochek device.
- Social Behaviours [ Time Frame: Pre-Post Testing (following the 5-month intervention). Data has been collected, but is still being analyzed ]Semi-structured interviews with residents (participants and non-participants), family members and staff will be administered at the end of the study
- Metabolic Profile - High Density Lipoprotein Cholesterol [ Time Frame: Pre and post testing (before and after the 5-month intervention) ]High Density Lipoprotein (HDL) cholesterol was analyzed using the CardioChek Professional Analyzer system (PTS Diagnostics, Whitestown, Indiana, USA). A finger prick was conducted using a single use lancet and approximately 60 µL of whole blood was collected for this test.
- Metabolic Profile - Low Density Lipoprotein Cholesterol [ Time Frame: Pre-Post intervention (before and after 5-month intervention) ]Low-density lipoprotein was assessed using a CardioChek Professional Analyzer system (PTS Diagnostics, Whitestown, Indiana, USA).
- Metabolic Profile - Blood Glucose [ Time Frame: Pre-Post Intervention (before and after 5-month intervention) ]Fasted blood glucose was analyzed using a CardioChek Professional Analyzer system (PTS Diagnostics, Whitestown, Indiana, USA).
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | Child, Adult, Older Adult |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Resident at one of the selected LTC facilities;
- Able to provide consent or have a power of attorney agree on behalf of a resident to participate in the study;
- Able to walk for ten meters, with or without a walking aid; The main outcome is walking speed performed for a distance of 10 meters. Therefore, we want everyone who participates in the study to be able to complete the test at baseline. This way we can answer the main research question, while adhering to our sample size calculation.
Exclusion Criteria:
- If Identified by staff at the facility as too high risk for falling by participating in the intervention.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03796039
| Canada, New Brunswick | |
| Pine Grove Nursing Home | |
| Fredericton, New Brunswick, Canada, E3B 2J2 | |
Documents provided by Danielle Bouchard, University of New Brunswick:
| Responsible Party: | Danielle Bouchard, Associate Investigator, University of New Brunswick |
| ClinicalTrials.gov Identifier: | NCT03796039 |
| Other Study ID Numbers: |
CAT2018-15 |
| First Posted: | January 8, 2019 Key Record Dates |
| Results First Posted: | July 6, 2021 |
| Last Update Posted: | July 13, 2021 |
| Last Verified: | July 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Long Term Care Physical Function |
|
Frailty Pathologic Processes |

